Lux Capital's Zavain Dar on Investing and Drug Discovery
Our guest today is Zavain Dar, a partner at Lux Capital and a founding investor in Anagenex. He speaks about his investments in cutting-edge medical tech companies, especially in the drug discovery space. He also describes common pitfalls faced by medical start-ups and gives advice to aspiring entrepreneurs. Pranav and Adriel first discuss Pfizer-BioNTech's and Moderna's COVID mRNA vaccines and then provide context for the interview, which starts at 7:02. If you like what you hear, let a friend know, subscribe wherever you get your podcasts, and connect with us on Twitter @AIHealthPodcast.